Acting NIH Infectious Disease Institute Head Resigns
Acting head of NIH’s infectious disease institute reported to have stepped down via @HelenBranswell @AnilOza16 https://t.co/YiUgVJpHb3
Aid Cuts Fuel DRC Ebola Surge, Hindering Control
NEW: The Trump admin's foreign aid cuts have hampered infection control in the DRC as the country's Ebola outbreak grows, people involved across the region tell me https://t.co/BpAnbXcsYh
CDC Retires Its Cruise Ship Health Monitoring Program
Amid plenty of hantavirus headlines... The official leading CDC’s cruise ship program has retired, according to an internal announcement obtained by STAT https://t.co/NTjmeIhWdB
Kennedy Misses Deadline, Fuels Transparency Concerns
Kennedy missed a Friday deadline to release details of an HHS contract with a longtime vaccine critic. Democratic lawmakers say it’s part of a larger pattern of the secretary ignoring his promises of “radical transparency” https://t.co/ICAsieVw9Y
Trump’s Drug Pricing Deals Underdeliver on Promised Cuts
Trump celebrated closing the first round of 17 drug pricing deals, now looking ahead to many more. But the reality of the deals, so far, have fallen short of grand promises the president made. https://t.co/QmhvZNgNyI
CMS Threatens States with Audits and Federal Scrutiny
CMS will ask states for new health provider audits, Oz says. If states don't take it 'seriously,' they could become targets of further federal scrutiny. https://t.co/IIBNZ8oWrM
Trump’s CDC Nominee Sparks Doubt over Public Health Direction
Trump's CDC pick is raising questions about the future of public health policy in his administration — and the power of the MAHA movement w/ @HelenBranswell @ChelseaCirruzzo https://t.co/UCILcMTpnQ
Joe Rogan's Text Spurs Federal Psychedelic Policy Shift
How a text from Joe Rogan helped remake the federal government's approach to psychedelics https://t.co/8j55tEgdx6
RFK Jr. Hearing Reveals Changing Health Care Politics
RFK Jr.'s first in a marathon series of hearings offers a window into a shifting politics of health care — for the Trump administration and Democrats alike w/ @ChelseaCirruzzo https://t.co/uZQqM1ximT
Small Pharma Must Strike Pricing Deal in 180 Days
New: Small pharma companies are in talks with the White House to sign drug pricing deals of their own. Small companies will have to cut a deal in the next 180 days to fully avoid tariffs on branded drugs. https://t.co/XFalvi3i3D
FDA Chief Outlines Agency’s Food Agenda to Congress
Amid the Trump administration's focus on food, a key FDA leader briefs lawmakers on the agency's plans https://t.co/SrXI4ObmGF
White House Drug Pricing Bill Details Revealed, Previewed by Insiders
Early details of what's in the White House's drug pricing bill text — and who's getting a sneak peek of it https://t.co/Yt8usm4yOa
Promising Therapeutics' Future at Risk Under Trump FDA
The future of promising therapeutics is on the line in the Trump administration's FDA, says the agency's former commissioner https://t.co/vyt49FkDsb
CMS and FDA at Critical Junctures Discussed at STATBreakthrough
Many interesting conversations ahead today at #STATBreakthrough — including on CMS and FDA, both at critical junctures: https://t.co/aThGw2QEfw
Trump Pushes Drug Pricing Overhaul Despite Congressional Resistance
The Trump administration is "gearing up for war" to push Congress to codify its drug pricing policy — despite little appetite for it on the Hill. Still, the pharma industry sees risk in the back-and-forth. https://t.co/DR2LotvXFq